Impact of Intensity-Modulated Radiotherapy on Health-Related Quality of Life for Head and Neck Cancer Patients: Matched-Pair Comparison with Conventional Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.67, issue.5, pp.1309-1317, 2007. ,
DOI : 10.1016/j.ijrobp.2006.11.012
Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients, Journal of Clinical Oncology, vol.25, issue.31, pp.4873-4879, 2007. ,
DOI : 10.1200/JCO.2007.11.5501
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial, The Lancet Oncology, vol.12, issue.2, pp.127-136, 2011. ,
DOI : 10.1016/S1470-2045(10)70290-4
Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial, International Journal of Radiation Oncology*Biology*Physics, vol.66, issue.4, pp.981-991, 2006. ,
DOI : 10.1016/j.ijrobp.2006.06.013
Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer, International Journal of Radiation Oncology*Biology*Physics, vol.50, issue.3, pp.695-704, 2001. ,
DOI : 10.1016/S0360-3016(01)01512-7
Dose-Effect Relationships for the Submandibular Salivary Glands and Implications for Their Sparing by Intensity Modulated Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.2, pp.373-382, 2008. ,
DOI : 10.1016/j.ijrobp.2007.12.033
Impact of Salivary Gland Dosimetry on Post-IMRT Recovery of Saliva Output and Xerostomia Grade for Head-and-Neck Cancer Patients Treated With or Without Contralateral Submandibular Gland Sparing: A Longitudinal Study, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.5, pp.1479-1487, 2011. ,
DOI : 10.1016/j.ijrobp.2010.07.1990
Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer, Radiotherapy and Oncology, vol.78, issue.3, pp.270-275, 2006. ,
DOI : 10.1016/j.radonc.2006.02.017
Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: Sites of locoregional relapse and survival, Acta Oncologica, vol.49, issue.6, pp.735-742, 2012. ,
DOI : 10.3109/0284186X.2010.504735
Changing Failure Patterns in Oropharyngeal Squamous Cell Carcinoma Treated With Intensity Modulated Radiotherapy and Implications for Future Research, American Journal of Clinical Oncology, vol.29, issue.6, pp.606-612, 2006. ,
DOI : 10.1097/01.coc.0000242294.89536.d6
Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT, International Journal of Radiation Oncology*Biology*Physics, vol.53, issue.5, pp.1174-1184, 2002. ,
DOI : 10.1016/S0360-3016(02)02881-X
Defining the Risk of Involvement for Each Neck Nodal Level in Patients With Early T-Stage Node-Positive Oropharyngeal Carcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.5, pp.1356-1364, 2009. ,
DOI : 10.1016/j.ijrobp.2008.10.018
Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22), International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.5, pp.1333-1338, 2010. ,
DOI : 10.1016/j.ijrobp.2009.04.011
Use of Normal Tissue Complication Probability Models in the Clinic, International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.3, pp.10-19, 2010. ,
DOI : 10.1016/j.ijrobp.2009.07.1754
Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer, International Journal of Radiation Oncology*Biology*Physics, vol.46, issue.5, pp.1117-1126, 2000. ,
DOI : 10.1016/S0360-3016(99)00550-7
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC), International Journal of Radiation Oncology*Biology*Physics, vol.31, issue.5, pp.1341-1346, 1995. ,
DOI : 10.1016/0360-3016(95)00060-C
Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer, Radiotherapy and Oncology, vol.72, issue.2, pp.119-127, 2004. ,
DOI : 10.1016/j.radonc.2004.03.014
Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer, International Journal of Radiation Oncology*Biology*Physics, vol.55, issue.2, pp.312-321, 2003. ,
DOI : 10.1016/S0360-3016(02)03940-8
Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004???03, Radiotherapy and Oncology, vol.103, issue.1, pp.57-62, 2012. ,
DOI : 10.1016/j.radonc.2011.12.010
Upfront submandibular salivary gland transfer in pharyngeal cancers, Oral Oncology, vol.40, issue.9, pp.960-963, 2004. ,
DOI : 10.1016/j.oraloncology.2004.04.016
A Phase II Study of Submandibular Gland Transfer Prior to Radiation for Prevention of Radiation-induced Xerostomia in Head-and-Neck Cancer (RTOG 0244), International Journal of Radiation Oncology*Biology*Physics, vol.84, issue.2, pp.437-442, 2012. ,
DOI : 10.1016/j.ijrobp.2012.02.034